Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Case Rep Oncol
Egile Nagusiak: Fujimura, Taku, Tanita, Kayo, Sato, Yota, Kambayashi, Yumi, Furudate, Sadanori, Tsukada, Akira, Hashimoto, Akira, Aiba, Setsuya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2018
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836287/
https://ncbi.nlm.nih.gov/pubmed/29515406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486278
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak